Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Paul Terasaki

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Procedures

Living Beings

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Tissue and Organ Procurement

Geographic Areas

United States

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
51
Cecka, Michael
38
Takemoto, Steven
28
Gjertson, David
16
Busuttil, Ronald
8
Imagawa, David
5
Danovitch, Gabriel
5
Ament, Marvin
5
McDiarmid, Sue
4
Seu, Philip
3
Lee, Po-Chang
3
Cho, YW
2
Cho, Yong
2
Goldstein, Leonard
2
Lee, Po-Huang
2
Koka, Prasad

Sign-in to see all Coauthors

Publications

TOP 3
Lee Po-Chang; Zhu Lan; Terasaki Paul I; Everly Matthew J
HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
Glassock Richard J; Terasaki Paul I
The origins of collaborative organ salvaging and sharing: Los Angeles, 1967.
Lee Po-Chang; Terasaki Paul I; Takemoto Steven K; Lee Po-Huang; Hung Chung-Jye; Chen Yi-Lin; Tsai Alen; Lei Huan-Yao
All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Paul Terasaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lee Po-Chang; Zhu Lan; Terasaki Paul I; Everly Matthew J
HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
Transplantation 2009;88(4):568-74.
2007: Glassock Richard J; Terasaki Paul I
The origins of collaborative organ salvaging and sharing: Los Angeles, 1967.
Clinical transplants 2007;():289-93.
2002: Lee Po-Chang; Terasaki Paul I; Takemoto Steven K; Lee Po-Huang; Hung Chung-Jye; Chen Yi-Lin; Tsai Alen; Lei Huan-Yao
All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies.
Transplantation 2002;74(8):1192-4.
2000: Takemoto S K; Terasaki P I; Gjertson D W; Cecka J M
Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation.
The New England journal of medicine 2000;343(15):1078-84.
2000: Terasaki P I
Longmire lecture: my 50 years at the University of California, Los Angeles.
World journal of surgery 2000;24(7):828-33.
1999: Cho Y W; Cecka J M; Gjertson D W; Terasaki P I
Prolonged hypertension (> 10 years) is a significant risk factor in older cadaver donor renal transplants.
Transplantation proceedings 1999;31(1-2):1283.
1999: Takemoto S K; Cecka J M; Gjertson D W; Terasaki P I
Class I peptides involved in the indirect pathway of allorecognition.
Transplantation proceedings 1999;31(1-2):781.
1999: Maggard M A; Johnson C; Wang T; Terasaki P; Kupiec-Weglinski J W; Busuttil R W; Imagawa D K
Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response.
Transplantation proceedings 1999;31(1-2):728-9.
1999: Terasaki P I
History of some currently utilized procedures in transplantation.
Transplantation proceedings 1999;31(1-2):47-8.
1999: Terasaki P; Takemoto S
Impact of HLA system on organ transplantation: a critical review before the end of the millennium.
Advances in nephrology from the Necker Hospital 1999;29():163-75.
1998: Cho Y W; Terasaki P I; Cecka J M
High kidney graft survival rates using non-heart-beating trauma donors.
Transplantation proceedings 1998;30(7):3795-6.
1998: Lee P C; Lee P H; Shaw C K; Takemoto S K; Gjertson D W; Siauw P A; Terasaki P I
HLA epitopes for kidney allocation.
Transplantation proceedings 1998;30(7):3496-7.
1998: Hata Y; Cecka J M; Takemoto S; Ozawa M; Cho Y W; Terasaki P I
Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients.
Transplantation 1998;65(2):208-12.
1998: Terasaki P I; Cecka J M; Gjertson D W
Impact analysis: a method for evaluating the impact of factors in clinical renal transplantation.
Clinical transplants 1998;():437-41.
1998: Terasaki P I; Cecka J M
A gold medal for organ donors and donor families.
Clinical transplants 1998;():348.
1997: Terasaki P I; Gjertson D W; Cecka J M; Takemoto S; Cho Y W
Significance of the donor age effect on kidney transplants.
Clinical transplantation 1997;11(5 Pt 1):366-72.
1997: Takemoto S K; Terasaki P I
Evaluation of the transplant recipient and donor: molecular approach to tissue typing, flow cytometry and alternative approaches to distributing organs.
Current opinion in nephrology and hypertension 1997;6(3):299-303.
1997: Takemoto S K; Cecka J M; Terasaki P I
Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regrafts.
Transplantation proceedings 1997;29(1-2):1417.
1997: Terasaki P
1996 Medawar Prize Lecture.
Transplantation proceedings 1997;29(1-2):33-8.
1997: Cecka J M; Terasaki P I
Living donor kidney transplants: superior success rates despite histoincompatibilities.
Transplantation proceedings 1997;29(1-2):203.
1997: Cho Y W; Terasaki P I; Cecka J M; Gjertson D W; Takemoto S
Should excessive height and weight differences between the kidney donor and recipient be avoided?
Transplantation proceedings 1997;29(1-2):104-5.
1996: Bettinotti M P; Mitsuishi Y; Lau M; Silver H; Spence A; Terasaki P I
HLA-A* 1104: a new allele found in a Laotian family.
Tissue antigens 1996;48(6):717-9.
1996: Kobashigawa J A; Sabad A; Drinkwater D; Cogert G A; Moriguchi J D; Kawata N; Hamilton M A; Hage A; Terasaki P; Laks H
Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?
Circulation 1996;94(9 Suppl):II294-7.
1996: Terasaki P; Cecka M; Gjertson D; Takemoto S
Allocation of cadaver kidneys.
Lancet 1996;348(9036):1247.
1996: Dawson S; Imagawa D K; Johnson C; Cecka M; Terasaki P I; Shackleton C R; Busuttil R W
UCLA liver transplantation: analysis of immunological factors affecting outcome.
Artificial organs 1996;20(10):1063-72.
1996: Imagawa D K; Dawson S; Holt C D; Kirk P S; Kaldas F M; Shackleton C R; Seu P; Rudich S M; Kinkhabwala M M; Martin P; Goldstein L I; Murray N G; Terasaki P I; Busuttil R W
Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
Transplantation 1996;62(7):934-42.
1996: Terasaki P I; Gjertson D W; Cecka J M; Takemoto S
Fit and match hypothesis for kidney transplantation.
Transplantation 1996;62(4):441-5.
1996: Hirata M; Terasaki P I; Cho Y W
Cytomegalovirus antibody status and renal transplantation: 1987-1994.
Transplantation 1996;62(1):34-7.
1996: Cho Y W; Terasaki P I
Comparison of kidney graft survival in Asian and Caucasian patients transplanted in the United States.
Transplantation proceedings 1996;28(3):1571-3.
1996: Takemoto S; Terasaki P I
HLA compatibility can be predicted by matching only three residues with outward oriented sidechains.
Transplantation proceedings 1996;28(3):1264-6.
1996: Terasaki P I; Cho Y; Takemoto S; Cecka M; Gjertson D
Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival.
Transplantation proceedings 1996;28(3):1144-5.
1996: Hirata M; Cho Y W; Cecka J M; Terasaki P I
Patient death after renal transplantation--an analysis of its role in graft outcome.
Transplantation 1996;61(10):1479-83.
1996: Terasaki P I; Cecka J M; Gjertson D W; Takemoto S; Cho Y W; Yuge J
Risk rate and long-term kidney transplant survival.
Clinical transplants 1996;():443-58.
1995: Gjertson D W; Cecka J M; Terasaki P I
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.
Transplantation 1995;60(12):1384-8.
1995: Kobashigawa J A; Katznelson S; Laks H; Johnson J A; Yeatman L; Wang X M; Chia D; Terasaki P I; Sabad A; Cogert G A
Effect of pravastatin on outcomes after cardiac transplantation.
The New England journal of medicine 1995;333(10):621-7.
1995: Terasaki P I; Cecka J M; Gjertson D W; Takemoto S
High survival rates of kidney transplants from spousal and living unrelated donors.
The New England journal of medicine 1995;333(6):333-6.
1995: Weisz J M; Holland G N; Roer L N; Park M S; Yuge A J; Moorthy R S; Forster D J; Rao N A; Terasaki P I
Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California.
Ophthalmology 1995;102(7):1012-5.
1995: Cecka J M; Terasaki P I
Optimal use for older donor kidneys: older recipients.
Transplantation proceedings 1995;27(1):801-2.
1995: Chia D; Terasaki P; Acalinovich A; Chan H; Balan R
HLA DR typing by polymerase chain reaction in Terasaki trays.
Transplantation proceedings 1995;27(1):696-7.
1995: Takemoto S; Gjertson D W; Cecka J M; Terasaki P I
HLA matching for local pools using fewer HLA factors.
Transplantation proceedings 1995;27(1):675-7.
1995: Gjertson D W; Takemoto S; Cecka J M; Terasaki P I
Impact of allocating cadaveric kidneys solely to "centers of excellence" versus by HLA matching.
Transplantation proceedings 1995;27(1):653-5.
1995: Terasaki P I; Gjertson D W; Cecka J M; Takemoto S
Proposed HLA matching scheme for improved cadaveric kidney allocation.
Transplantation proceedings 1995;27(1):61-3.
1995: Terasaki P I; McClelland J D; Yuge J; Cecka J M; Gjertson D W; Takemoto S; Cho Y W
Advances in kidney transplantation: 1985-1995.
Clinical transplants 1995;():487-501.
1995: Cho Y W; Terasaki P I; Cecka J M
New variables reported to the UNOS registry and their impact on cadaveric renal transplant outcomes - a preliminary study.
Clinical transplants 1995;():405-15.
1995: Cecka J M; Terasaki P I
The UNOS scientific renal transplant registry. United Network for Organ Sharing.
Clinical transplants 1995;():1-18.
1994: Chia D; Terasaki P; Chan H; Acalinovich A; Maruya E; Saji H; Ware K
A new simplified method of gene typing.
Tissue antigens 1994;44(5):300-5.
1994: Takemoto S; Terasaki P I; Gjertson D W; Cecka J M
Equitable allocation of HLA-compatible kidneys for local pools and minorities.
The New England journal of medicine 1994;331(12):760-4.
1994: Takemoto S; Terasaki P I
Comparison of HLA matching protocols to maximize the number of compatible kidney recipients in small Asian pools.
Transplantation proceedings 1994;26(4):1879-80.
1994: Terasaki P I; Koyama H; Cecka J M; Gjertson D W
The hyperfiltration hypothesis in human renal transplantation.
Transplantation 1994;57(10):1450-4.
1994: Koyama H; Cecka J M; Terasaki P I
Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival.
Transplantation 1994;57(7):1064-8.
1994: Ogura K; Terasaki P I; Koyama H; Chia J; Imagawa D K; Busuttil R W
High one-month liver graft failure rates in flow cytometry crossmatch-positive recipients.
Clinical transplantation 1994;8(2 Pt 1):111-5.
1994: Cecka J M; Terasaki P I
Repeating HLA antigen mismatches in renal retransplants--a second class mistake?
Transplantation 1994;57(4):515-9.
1994: Terasaki P I; Yuge J; Cecka J M; Gjertson D W
Cytomegalovirus antibody status and kidney transplantation.
Clinical transplants 1994;():509-18.
1993: Chia D; Terasaki P; Chan H; Tonai R; Siauw P A
Direct detection of PCR products for HLA class II typing.
Tissue antigens 1993;42(3):146-9.
1993: Koyama S; Mitsuishi Y; Bibee K; Watanabe I; Terasaki P I
HLA associations with Menière's disease.
Acta oto-laryngologica 1993;113(5):575-8.
1993: Cecka J M; Gjertson D W; Cho Y; Terasaki P I
HLA polymorphisms, ethnicity, and graft survival: united network for organ sharing. UNOS Scientific Renal Transplant Registry.
Transplantation proceedings 1993;25(4):2446-7.
1993: Ogura K; Terasaki P I; Johnson C; Mendez R; Rosenthal J T; Ettenger R; Martin D C; Dainko E; Cohen L; Mackett T
The significance of a positive flow cytometry crossmatch test in primary kidney transplantation.
Transplantation 1993;56(2):294-8.
1993: Wang X M; Terasaki P I; Rankin G W; Chia D; Zhong H P; Hardy S
A new microcellular cytotoxicity test based on calcein AM release.
Human immunology 1993;37(4):264-70.
1993: Koka P; Chia D; Terasaki P I; Chan H; Chia J; Ozawa M; Lim E
The role of IgA anti-HLA class I antibodies in kidney transplant survival.
Transplantation 1993;56(1):207-11.
1993: Lim E C; Chia D; Gjertson D W; Koka P; Terasaki P I
In vitro studies to explain high renal allograft survival in IgA nephropathy patients.
Transplantation 1993;55(5):996-9.
1993: Takemoto S; Cecka J M; Gjertson D W; Terasaki P I
Six-antigen-matched transplants. Causes of failure.
Transplantation 1993;55(5):1005-8.
1993: Cecka J M; Gjertson D; Terasaki P I
Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high-risk groups?
Transplantation proceedings 1993;25(1 Pt 1):548-9.
1993: Ogura K; Koyama H; Takemoto S; Chia J; Johnson C; Terasaki P I
Flow cytometry crossmatching for kidney transplantation.
Transplantation proceedings 1993;25(1 Pt 1):245-6.
1993: Gjertson D W; Terasaki P I; Cecka J M; Takemoto S
Reduction of the center effect by HLA matching.
Transplantation proceedings 1993;25(1 Pt 1):215-6.
1993: Takemoto S; Terasaki P I; Maruya E; Park M S
Molecular matching for clinical kidney transplantation.
Transplantation proceedings 1993;25(1 Pt 1):206.
1993: Terasaki P I; Yuge J; Cecka J M; Gjertson D W; Takemoto S; Cho Y
Thirty-year trends in clinical kidney transplantation.
Clinical transplants 1993;():553-62.
1993: Maruya E; Takemoto S; Terasaki P I
HLA matching: identification of permissible HLA mismatches.
Clinical transplants 1993;():511-20.
1993: Cecka J M; Terasaki P I
The UNOS Scientific Renal Transplant Registry.
Clinical transplants 1993;():1-18.
1992: Yanagiya A; Terasaki P I; Iwaki Y; Ho B B; Drinkwater D C; Laks H
Prolongation of second heart transplants in rats.
Transplantation 1992;54(4):690-4.
1992: Mitsuishi Y; Terasaki P I
HLA matching effect on five-year graft survival and half-life in the cyclosporine era.
Kidney international. Supplement 1992;38():S172-5.
1992: Takemoto S; Terasaki P I; Cecka J M; Cho Y W; Gjertson D W
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
The New England journal of medicine 1992;327(12):834-9.
1992: Ogura K; Koyama H; Takemoto S; Terasaki P I; Busuttil R W
Significance of a positive crossmatch on outcome in human liver transplantation.
Transplantation proceedings 1992;24(4):1465.
1992: Cecka J M; Gjertson D; Terasaki P I
Superior renal allograft survival among Asian recipients.
Transplantation proceedings 1992;24(4):1431-2.
1992: Takemoto S; Carnahan E; Terasaki P I
Beneficial effect of sharing six-antigen-matched cadaver kidneys in the United States.
Transplantation proceedings 1992;24(4):1310-1.
1992: Takemoto S; Terasaki P I; Park M S; Clark B D
Effect of mismatching serologically defined residues on kidney transplant survival.
Transplantation proceedings 1992;24(4):1266-8.
1992: Sameshima Y; Chia D; Terasaki P I; Imagawa D K; Busuttil R W
Appearance of the tumor marker CA 19-9 in liver transplant patients during rejection episodes.
Transplantation 1992;53(3):580-2.
1992: Gjertson D W; Terasaki P I
The large center variation in half-lives of kidney transplants.
Transplantation 1992;53(2):357-62.
1992: Cecka J M; Cho Y W; Terasaki P I
Analyses of the UNOS Scientific Renal Transplant Registry at three years--early events affecting transplant success.
Transplantation 1992;53(1):59-64.
1992: McDiarmid S V; Busuttil R W; Terasaki P; Vargas J H; Ament M E
OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipients.
Journal of pediatric gastroenterology and nutrition 1992;14(1):86-91.
1991: McDiarmid S V; Millis M J; Terasaki P I; Ament M E; Busuttil R W
OKT3 prophylaxis in liver transplantation.
Digestive diseases and sciences 1991;36(10):1418-26.
1991: Takemoto S; Terasaki P I
HLA peptide matching.
Transplantation proceedings 1991;23(4):2039-42.
1991: Kato Y; Mitsuishi Y; Cecka M; Hopfield J; Hunt L; Champlin R; Terasaki P I; Gajewski J L
HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants.
Transplantation 1991;52(2):374-6.
1991: McDiarmid S V; Busuttil R W; Levy P; Millis M J; Terasaki P I; Ament M E
The long-term outcome of OKT3 compared with cyclosporine prophylaxis after liver transplantation.
Transplantation 1991;52(1):91-7.
1991: Soon-Shiong P; Terasaki P I; Lanza R P
Immunocytochemical identification of monoclonal antibodies with binding activity to acinar cells but not islets.
Pancreas 1991;6(3):318-23.
1991: Gjertson D W; Terasaki P I; Takemoto S; Mickey M R
National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs.
The New England journal of medicine 1991;324(15):1032-6.
1991: Chia D; Terasaki P I; Chan H; Ozawa M
Binding of IgG to B cell via HLA molecules.
Tissue antigens 1991;37(2):49-55.
1991: Teramoto K; Baquerizo A; Imagawa D K; Seu P; Hart J; Dempsey R A; Terasaki P I; Kamada N; Busuttil R W
Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibody.
Transplantation proceedings 1991;23(1 Pt 1):602-3.
1991: Terasaki P I; Cecka J M; Cho Y; Takemoto S; Mickey M R
A report from the UNOS Scientific Renal Transplant Registry.
Transplantation proceedings 1991;23(1 Pt 1):53-4.
1991: Terasaki P I; Takemoto S; Park M S; Cecka J M; Mickey M R
Molecular HLA matching.
Transplantation proceedings 1991;23(1 Pt 1):365-7.
1991: Takemoto S; Carnahan E; Terasaki P I
A report of 504 six antigen-matched transplants.
Transplantation proceedings 1991;23(1 Pt 2):1318-20.
1991: Cicciarelli J; Terasaki P
Matching cadaver transplants achieve graft survivals comparable to living related transplants.
Transplantation proceedings 1991;23(1 Pt 2):1284-8.
1991: Feduska N J; Chia D; Terasaki P I; Sugich L
Effect of anti-Fab antibodies on renal allografts.
Transplantation proceedings 1991;23(1 Pt 2):1277-8.
1991: Terasaki P I; Cecka J M; Lim E; Takemoto S; Cho Y; Gjertson D; Ogura K; Koyama H; Mitsuishi Y; Yuge J
UCLA and UNOS Registries. Overview.
Clinical transplants 1991;():409-30.
1990: Imagawa D K; Millis J M; Olthoff K M; Seu P; Dempsey R A; Hart J; Terasaki P I; Wasef E M; Busuttil R W
The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats.
Transplantation 1990;50(2):189-93.
1990: McDiarmid S V; Millis M; Terashita G; Ament M E; Busuttil R; Terasaki P
Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients.
Transplantation proceedings 1990;22(4):1774-6.
1990: Prochazka E J; Terasaki P I; Park M S; Goldstein L I; Busuttil R W
Association of primary sclerosing cholangitis with HLA-DRw52a.
The New England journal of medicine 1990;322(26):1842-4.
1990: Imagawa D K; Millis J M; Olthoff K M; Seu P; Dempsey R A; Hart J; Terasaki P I; Busuttil R W
Anti-tumor necrosis factor antibody enhances allograft survival in rats.
The Journal of surgical research 1990;48(4):345-8.
1990: Soon-Shiong P; Fujioka T; Terasaki P; Heintz R; Lanza R P
Islet purification by a novel immunomicrosphere cell depletion technique.
Transplantation proceedings 1990;22(2):780-1.
1990: Fujioka T; Terasaki P I; Heintz R; Merideth N; Lanza R P; Zheng T L; Soon-Shiong P
Rapid purification of islets using magnetic microspheres coated with anti-acinar cell monoclonal antibodies.
Transplantation 1990;49(2):404-7.
1990: Iwaki Y; Cecka J M; Terasaki P I
The transfusion effect in cadaver kidney transplants--yes or no.
Transplantation 1990;49(1):56-9.
1990: Takemoto S; Carnahan E; Terasaki P I
Report on 604 six-antigen-matched transplants.
Clinical transplants 1990;():485-95.
1990: Cecka J M; Terasaki P I
The UNOS Scientific Renal Transplant Registry--1990.
Clinical transplants 1990;():1-10.
1990: Soon-Shiong P; Heintz R; Fujioka T; Terasaki P; Merideth N; Lanza R P
Utilization of anti-acinar cell monoclonal antibodies in the purification of rat and canine islets.
Hormone and metabolic research. Supplement series 1990;25():45-50.
1989: Takemoto S; Terasaki P I
A comparison of kidney transplant survival in white and black recipients.
Transplantation proceedings 1989;21(6):3865-8.
1989: Wang G X; Terashita G Y; Terasaki P I
Platelet crossmatching for kidney transplants by flow cytometry.
Transplantation 1989;48(6):959-61.
1989: Togashi H; Ghoneum M; Takasugi M; Kasai K; Mugishima H; Billing R; Terasaki P I
A monoclonal antibody 1A6 to T-cell recognizes a common antigen expressed on lymphocytes from normal and leukemic patients, and inhibits NK cell activity.
Hematological oncology 1989;7(3):233-42.
1989: Terasaki P I; Mickey M R; Cecka M; Iwaki Y; Cicciarelli J
Clinical kidney transplants, 1988.
Immunology letters 1989;21(1):33-8.
1989: Soon-Shiong P; Heintz R; Terasaki P
Identification of novel blood group-reactive monoclonal antibodies cytotoxic to human acinar cells but not islets.
Transplantation proceedings 1989;21(1 Pt 3):2622-3.
1989: Chia D; Terasaki P I; Casuga E; Ozawa M
Influence of antimucin antibody in kidney transplantation.
Transplantation proceedings 1989;21(1 Pt 1):698-9.
1989: Iwaki Y; Terasaki P I; Lau M; Yanagiya A; Feduska N; Cross D; Diethelm A; Barger B; Senitzer D; Langley J
Prospective study of kidney transplantation across positive T warm crossmatches.
Transplantation proceedings 1989;21(1 Pt 1):693.
1989: Cicciarelli J; Terasaki P
Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
Transplantation proceedings 1989;21(1 Pt 1):659-60.
1989: Terasaki P; Mickey M R; Iwaki Y; Cicciarelli J; Cecka M; Cook D; Yuge J
Long-term survival of kidney grafts.
Transplantation proceedings 1989;21(1 Pt 1):615-7.
1989: Baquerizo A; Kamada N; Millis J M; Iwaki Y; Terasaki P I; Hart J; Pera C; Busuttil R W
Donor-specific serum transfusion prolongs survival of orthotopic liver transplantation in the rat.
Transplantation proceedings 1989;21(1 Pt 1):1179-80.
1989: Mickey M R; Cook D J; Terasaki P I
Recipient pool sizes for prioritized HLA matching.
Transplantation 1989;47(2):401-3.
1989: McDiarmid S V; Cook D J; Mickey M R; Ament M E; Busuttil R W; Terasaki P I
The development of a lymphocyte population with suppressor phenotype after successful liver transplantation.
Transplantation proceedings 1989;21(1 Pt 1):423-4.
1989: Takiff H; Iwaki Y; Cecka M; Terasaki P I
The benefit and underutilization of sharing kidneys for better histocompatibility.
Transplantation 1989;47(1):102-5.
1989: Terasaki P I
Beneficial effect of transfusion on kidney transplants.
Vox sanguinis 1989;57(2):158-60.
1989: McClelland J; Terasaki P I; Berne T; Brennan L P; Bretan P; Cohen A; Dainko E; Danovitch G; Ettenger R; Lieberman E
Evaluation of the UNOS point system for kidney recipient selection.
Clinical transplants 1989;():471-6.
1989: Cecka J M; Corcoran S; Takemoto S; Cho Y; Mickey M R; Terasaki P I
The UNOS Scientific Renal Transplant Registry.
Clinical transplants 1989;():1-8.
1989: Terasaki P I; Park M S; Takemoto S; Cecka J M; Clark B; Corcoran S; Cicciarelli J; Barbetti A; Yuge J; Carnahan E
Overview and epitope matching.
Clinical transplants 1989;():499-516.
1988: Cook D J; Terasaki P I
Cyclosporine A and histocompatibility in kidney transplantation.
Transplantation proceedings 1988;20(3 Suppl 3):244-8.
1988: Takiff H; Cook D J; Himaya N S; Mickey M R; Terasaki P I
Dominant effect of histocompatibility on ten-year kidney transplant survival.
Transplantation 1988;45(2):410-5.
1988: Takiff H; Novak M; Iwaki Y; Terasaki P I
Low-dose cyclosporine maintenance therapy after immunosuppressive induction in a rat cardiac transplant model.
Transplantation 1988;45(2):297-301.
1988: Cecka J M; Cicciarelli J; Mickey M R; Terasaki P I
Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
Transplantation 1988;45(1):81-6.
1988: Soon-Shiong P; Heintz R; Terasaki P
Characterization of monoclonal antibodies CBL3 and TT62 with differing antigenic determinants specific for isolated human islets.
Biochemical and biophysical research communications 1988;150(2):775-80.
1988: Terasaki P I; Cecka J M; Takemoto S; Yuge J; Mickey M R; Park M S; Iwaki Y; Cicciarelli J; Cho Y
Clinical transplants 1988. Overview.
Clinical transplants 1988;():409-34.
1988: Wang G X; Terashita G Y; Terasaki P I
Crossmatching on platelets by flow cytometry.
Clinical transplants 1988;():381-5.
1988: Cook D J; Terasaki P I; Iwaki Y; Terashita G; Fujikawa J; Gera J; Takeda A; Danovitch G; Rosenthal J T; Fine R
Flow cytometry crossmatching for kidney transplantation.
Clinical transplants 1988;():375-80.
1987: Cook D J; Graver B; Terasaki P I
ABO incompatibility in cadaver donor kidney allografts.
Transplantation proceedings 1987;19(6):4549-52.
1987: Cecka J M; Breidenthal S E; Terasaki P I
Low anti-A and anti-B titers in some type O patients may permit renal transplantation across the ABO barrier.
Transplantation proceedings 1987;19(6):4507-10.
1987: Cecka J M; Terasaki P I
Improvement of kidney transplant regraft results by using trauma death donors.
Transplantation 1987;44(6):792-5.
1987: Roy R; Terasaki P I; Chia D; Mickey M R
Low kidney graft survival in Lewis negative patients after regrafting and newer matching schemes for Lewis.
Transplantation proceedings 1987;19(6):4498-502.
1987: Clark B D; Park M S; Tonai R; Terasaki P I
Serologic and biochemical analysis of HLA B15 and B5 complexes.
Human immunology 1987;20(1):47-57.
1987: Cecka J M; Breidenthal S; Terasaki P I
Direct blood group typing of forensic samples using a simple monoclonal antibody assay.
Forensic science international 1987;34(3):205-16.
1987: Iwaki Y; Cook D J; Terasaki P I; Lau M; Terashita G Y; Danovitch G; Fine R; Ettenger R; Mendez R; Kavalich A
Flow cytometry crossmatching in human cadaver kidney transplantation.
Transplantation proceedings 1987;19(1 Pt 1):764-6.
1987: Mickey M R; Berne T V; Kahan B D; Salvatierra O; Starzl T E; Terasaki P I
HLA matching assessed from early graft function.
Transplantation proceedings 1987;19(1 Pt 1):681-2.
1987: Cook D J; Cecka J M; Terasaki P I
HLA-DR1 recipients have the highest kidney transplant survival.
Transplantation proceedings 1987;19(1 Pt 1):675-7.
1987: Takiff H; Mickey M R; Cicciarelli J; Terasaki P I
Factors important in ten-year kidney graft survival.
Transplantation proceedings 1987;19(1 Pt 1):666-8.
1987: Cicciarelli J; Terasaki P I; Cecka M; Mickey M R
Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
Transplantation proceedings 1987;19(1 Pt 1):647-9.
1987: Cecka J M; Cicciarelli J; Terasaki P I
The effect of cyclosporine A in cadaver donor retransplants: a surprising effect of the sex of the donor.
Transplantation proceedings 1987;19(1 Pt 3):1842-4.
1987: Tiwari J; Terasaki P I; Mickey M R
Factors influencing kidney graft survival in the cyclosporine era: a multivariate analysis.
Transplantation proceedings 1987;19(1 Pt 3):1839-41.
1987: Takiff H; Novak M; Yin L; Iwaki Y; Terasaki P I
Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants.
Transplantation proceedings 1987;19(1 Pt 2):1452-4.
1987: Cook D J; Terasaki P I; Iwaki Y; Terashita G; Takeda A; Fujikawa J; Lau M; Danovitch G; Rosenthal J T; Fine R
The flow cytometry crossmatch in kidney transplantation.
Clinical transplants 1987;():409-14.
1986: Kawahara M; Terasaki P I; Chia D; Johnson C; Hermes M; Tokita K
Use of four monoclonal antibodies to detect tumor markers.
Cancer 1986;58(9):2008-12.
1986: Terasaki P I; Cecka J M; Berne T; Brennan P; Cohen J L; Dainko E; Danovitch G; Ettenger R; Glassock R; Mackett T
The Los Angeles Transplant Society.
Clinical transplants 1986;():61-7.
1985: Kawahara M; Chia D; Terasaki P I; Roumanas A; Sugich L; Hermes M; Iguro T
Detection of sialylated LewisX antigen in cancer sera using a sandwich radioimmunoassay.
International journal of cancer. Journal international du cancer 1985;36(4):421-5.
1983: Mugishima H; Terasaki P I; Sueyoshi A; Billing R
Human complement in treatment of bone marrow cells with monoclonal antibody.
Lancet 1983;2(8360):1194-5.
1983: Horimi T; Terasaki P I; Chia D; Sasaki N
Factors influencing the paradoxical effect of transfusions on kidney transplants.
Transplantation 1983;35(4):320-3.
1983: Horimi T; Chia D; Terasaki P I; Matsumoto T; Iwaki Y; Takahashi H
Association of B cold cytotoxins and anti-F (ab')2 antibodies with inhibition of mixed lymphocyte culture.
Japanese journal of medical science & biology 1983;36(1):11-6.
1982: Chia D; Horimi T; Terasaki P I; Hermes M
Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
Transplantation proceedings 1982;14(2):322-4.
1982: Horimi T; Chia D; Terasaki P I; Ayoub G; Iwaki Y
Association of anti-F(ab')2 antibodies with higher kidney transplant survival rates.
Transplantation 1982;33(6):603-5.

Sign-in to see more